139 related articles for article (PubMed ID: 37740611)
21. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1.
Odermatt A; Da Cunha T; Penno CA; Chandsawangbhuwana C; Reichert C; Wolf A; Dong M; Baker ME
Biochem J; 2011 Jun; 436(3):621-9. PubMed ID: 21453287
[TBL] [Abstract][Full Text] [Related]
22. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R
Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595
[TBL] [Abstract][Full Text] [Related]
23. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
Morris DJ; Latif SA; Hardy MP; Brem AS
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
[TBL] [Abstract][Full Text] [Related]
24. 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
Valsamakis G; Anwar A; Tomlinson JW; Shackleton CH; McTernan PG; Chetty R; Wood PJ; Banerjee AK; Holder G; Barnett AH; Stewart PM; Kumar S
J Clin Endocrinol Metab; 2004 Sep; 89(9):4755-61. PubMed ID: 15356090
[TBL] [Abstract][Full Text] [Related]
25. Detailed analysis of cortisol, cortisone and their tetrahydro- and allo-tetrahydrometabolites in human urine by LC-MS/MS.
Kosicka K; Siemiątkowska A; Pałka D; Szpera-Goździewicz A; Bręborowicz GH; Główka FK
J Pharm Biomed Anal; 2017 Jun; 140():174-181. PubMed ID: 28359965
[TBL] [Abstract][Full Text] [Related]
26. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
27. 11β-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline.
MacLullich AM; Ferguson KJ; Reid LM; Deary IJ; Starr JM; Wardlaw JM; Walker BR; Andrew R; Seckl JR
Neurobiol Aging; 2012 Jan; 33(1):207.e1-8. PubMed ID: 20961667
[TBL] [Abstract][Full Text] [Related]
28. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
Diederich S; Quinkler M; Mai K; Schöneshöfer M; Baehr V; Pfeiffer A; Oelkers W; Eigendorff E
Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis.
Jun YJ; Park SJ; Hwang JW; Kim TH; Jung KJ; Jung JY; Hwang GH; Lee SH; Lee SH
Clin Exp Allergy; 2014 Feb; 44(2):197-211. PubMed ID: 24447082
[TBL] [Abstract][Full Text] [Related]
30. Effects of bile acids on rat hepatic microsomal type I 11beta-hydroxysteroid dehydrogenase.
Maeda Y; Naganuma S; Niina I; Shinohara A; Koshimoto C; Kondo K; Chijiiwa K
Steroids; 2010 Feb; 75(2):164-8. PubMed ID: 19948178
[TBL] [Abstract][Full Text] [Related]
31. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.
Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR
Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798
[TBL] [Abstract][Full Text] [Related]
32. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
Agha A; Behan LA; Forde H; Taylor NF; Smith D; Thompson CJ; Drake WM; Monson JP
Endocr Pract; 2018 Oct; 24(10):875-881. PubMed ID: 29975580
[TBL] [Abstract][Full Text] [Related]
33. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
[TBL] [Abstract][Full Text] [Related]
34. 7alpha- and 7beta-hydroxy-epiandrosterone as substrates and inhibitors for the human 11beta-hydroxysteroid dehydrogenase type 1.
Hennebert O; Pernelle C; Ferroud C; Morfin R
J Steroid Biochem Mol Biol; 2007; 105(1-5):159-65. PubMed ID: 17624766
[TBL] [Abstract][Full Text] [Related]
35. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
Ge R; Huang Y; Liang G; Li X
Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
[TBL] [Abstract][Full Text] [Related]
36. 11β-hydroxysteroid dehydrogenase type 1 is associated with antiretroviral therapy-induced increase in low-density lipoprotein cholesterol
.
Niki K; Harada K; Hikasa S; Tsugane M; Ueda M; Higasa S; Kimura T; Takagi T; Uejima E
Int J Clin Pharmacol Ther; 2019 Jun; 57(6):298-305. PubMed ID: 30848242
[TBL] [Abstract][Full Text] [Related]
37. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
[TBL] [Abstract][Full Text] [Related]
38. Can 11β-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease?
Cooper MS; Kriel H; Sayers A; Fraser WD; Williams AM; Stewart PM; Probert CS; Tobias JH
Calcif Tissue Int; 2011 Sep; 89(3):246-51. PubMed ID: 21695543
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study.
Sagmeister MS; Taylor AE; Fenton A; Wall NA; Chanouzas D; Nightingale PG; Ferro CJ; Arlt W; Cockwell P; Hardy RS; Harper L
Clin Endocrinol (Oxf); 2019 Jan; 90(1):241-249. PubMed ID: 30358903
[TBL] [Abstract][Full Text] [Related]
40. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
